The information highlighted (if any) are the most recent updates for this brand.
Meningococcal group A, C, W-135 & Y conjugate vaccine.
One dose (0.5 mL) contains: The active substances are: Neisseria meningitidis group A polysaccharide1 10 micrograms, Neisseria meningitidis group C polysaccharide1 10 micrograms, Neisseria meningitidis group Y polysaccharide1 10 micrograms, Neisseria meningitidis group W polysaccharide1 10 micrograms.
1 Conjugated to tetanus toxoid carrier protein 55 micrograms.
Excipients/Inactive Ingredients: The other ingredients are: sodium chloride, sodium acetate, water for injections.
MenQuadfi works by stimulating the vaccinated person natural defense (immune system), to produce protective antibodies against the bacteria.
MenQuadfi only helps to protect against illnesses caused by Neisseria meningitidis types A, C, W and Y.
It does not protect against infections caused by other types of Neisseria meningitidis.
It does not protect against meningitis or septicaemia caused by other bacteria or viruses.
As with any vaccine, MenQuadfi may not fully protect all the people who are vaccinated.
MenQuadfi is a vaccine that can be given to children from 1 year of age, adolescents and adults.
MenQuadfi helps to protect against infections caused by a type of bacteria (germs) called "Neisseria meningitidis", specifically against types A, C, W and Y.
Neisseria meningitidis bacteria (also called meningococci) can be passed from person to person and can cause serious and sometimes life-threatening infections, such as: Meningitis: an inflammation of the tissues that surround the brain and spinal cord; Septicaemia: an infection of the blood.
Both infections can result in serious disease with long lasting effects or possibly death.
MenQuadfi should be used in accordance with official national guidelines.
MenQuadfi is given by the doctor or nurse as a 0.5 mL injection in the muscle. It is given in the upper arm or in the thigh depending on the age and how much muscle the patient or the child has.
Do not have MenQuadfi if the patient or the child is allergic to any of the active substances or any of the other ingredients of this vaccine (see Description) or have experienced a previous allergic reaction to this vaccine.
If not sure, talk to the doctor, pharmacist or nurse before given MenQuadfi.
Talk to the doctor, pharmacist or nurse before vaccination with MenQuadfi if the patient or the child has: an infection with high temperature (over 38°C). If this applies, the vaccination will be given after the infection is under control. There is no need to delay vaccination for a minor infection such as a cold. However, talk to the doctor, pharmacist or nurse first.
A bleeding problem or bruise easily.
Ever fainted from an injection. Fainting, sometimes accompanied by falling, can occur (mostly in adolescents) after, or even before, any injection.
A weak immune system (such as due to HIV infection, other disease, or use of a medicine that affect the immune system), as the patient or child may not fully benefit from having MenQuadfi.
If any of the previously mentioned apply to the patient or child (or if not sure whether they apply), talk to the doctor, pharmacist or nurse before the patient or the child is given MenQuadfi. As with any vaccine, MenQuadfi may not fully protect all of those who get the vaccine.
MenQuadfi contains sodium: This medicine contains less than 1 mmol sodium (23 mg) per dose, this means that it is essentially 'sodium-free'.
Driving and using machines: MenQuadfi is not likely to affect the ability to drive, cycle or use machines. However, do not drive, cycle or use any machines if not feeling well.
If pregnant, breast-feeding, think may be pregnant, or is planning to have a baby, ask the doctor, pharmacist, or nurse for advice before receiving MenQuadfi.
Like all vaccines, MenQuadfi can cause side effects, although not everybody gets them. If the patient or the child gets any of these symptoms after the vaccination: itchy skin rash, shortness of breath, swelling of the face or tongue.
Contact the doctor immediately. This could be signs of an allergic reaction.
Possible side effects in children aged 12 to 23 months: Very common: (may affect more than 1 in 10 children): tenderness, redness, or swelling where the injection was given, feeling irritable, crying, loss of appetite, feeling drowsy.
Common (may affect up to 1 in 10 children): fever, vomiting, diarrhoea.
Uncommon (may affect up to 1 in 100 people): difficulty sleeping, hives, itching, bruising, firmness, or rash where the injection was given.
Possible side effects in children (2 years of age and older), adolescents and adults: Very common (may affect more than 1 in 10 people): pain where the injection was given, muscle pain, headache, generally feeling unwell.
Common (may affect up to 1 in 10 people): redness or swelling where the injection was given, fever.
Uncommon (may affect up to 1 in 100 people): itching, warmth, bruising or rash where the injection was given, vomiting, feeling dizzy, nausea, fatigue (feeling tired).
Rare (may affect up to 1 in 1,000 people): enlarged lymph nodes; diarrhoea, stomach pain; hives, itching, rash, pain in the arms or legs, chills, pain in the armpit; injection site firmness.
Reporting of side effects: If the patient or the child gets any side effects, talk to the doctor, pharmacist, or nurse. This includes any possible side effects not listed in this product information. By reporting side effects, to help provide more information on the safety of this medicine.
Other medicines and MenQuadfi: Tell the doctor, pharmacist, or nurse if the patient or child is taking, have recently taken or might take any other vaccines or medicines, including medicines obtained without a prescription.
In particular, tell the doctor, pharmacist, or nurse if the patient is taking any medicines that affect the immune system, such as: high-dose corticosteroids, chemotherapy.
MenQuadfi may be given at the same time as other vaccines at separate injection site during the same visit. These include the vaccines that protect against measles, mumps, rubella, varicella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b, hepatitis B, pneumococcal and human papillomavirus infections.
Store in a refrigerator (2°C to 8°C).
Do not freeze.
Do not throw away any medicines via wastewater or household waste.
Ask the pharmacist how to throw away medicines no longer use. These measures will help to protect the environment.
J07AH - Meningococcal vaccines ; Used for active immunizations.
MenQuadfi inj
0.5 mL x 1's;0.5 mL x 5 × 1's